| RS2530896937 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2530897266 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2530899339 |
MSH6
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2530899972 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530901028 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2530903802 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2530905739 |
WDFY3
|
Health Risk |
Likely pathogenic |
Microcephaly 18, primary |
| RS2530906062 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530906188 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530906897 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530907604 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2530908124 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530908758 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530908786 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530911498 |
WDFY3
|
Health Risk |
Likely pathogenic |
Microcephaly 18, primary |
| RS2530912560 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530913503 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2530914946 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530915229 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530915318 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530915443 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530915554 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530925226 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2530925634 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530926325 |
MAP3K1
|
Health Risk |
Pathogenic |
46, XY sex reversal 6 |
| RS2530929818 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530932127 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530933851 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530936224 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530936412 |
FBXO11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530936478 |
FBXO11
|
Health Risk |
Pathogenic |
— |
| RS2530936585 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530936889 |
FBXO11;MSH6
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530937941 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530945305 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530947103 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530947238 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530947513 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530948932 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2530953333 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530953573 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530954124 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 36 with lymphoproliferation, Agammaglobulinemia 7 |
| RS2530954242 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2530954352 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530954644 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530954961 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530955325 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530957121 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530957601 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530958634 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530961037 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530961555 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530962740 |
PDE4D
|
Health Risk |
Pathogenic |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS2530962892 |
PDE4D
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS2530963146 |
FBXO11
|
Health Risk |
Pathogenic |
— |
| RS2530964031 |
MAP3K1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 6 |
| RS2530965573 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530965674 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530965720 |
SLCO2A1
|
Health Risk |
Pathogenic |
— |
| RS2530966244 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530966816 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530967533 |
ANKRD17
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD17-related disorder, Chopra-Amiel-Gordon syndrome |
| RS2530967790 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530967894 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530968026 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530968047 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530970163 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530970295 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS2530971773 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS2530972775 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530973212 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2530973442 |
FBXO11
|
Health Risk |
Pathogenic |
— |
| RS2530975216 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
7 conditions, 7 conditions |
| RS2530977738 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2530977941 |
COL7A1
|
Health Risk |
Pathogenic |
COL7A1-related disorder, COL7A1-related disorder |
| RS2530978135 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2530978371 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530982887 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530983801 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530983823 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2530987988 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2530988286 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530989090 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530989113 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2530991909 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530992842 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2530998107 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2530998325 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531000229 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531000611 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 2 |
| RS2531000854 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2531000911 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531000994 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531000996 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2531001005 |
PIK3R1
|
Health Risk |
Pathogenic |
SHORT syndrome, Agammaglobulinemia 7 |
| RS2531001159 |
PIK3R1
|
Health Risk |
Pathogenic |
Agammaglobulinemia 7, autosomal recessive |
| RS2531001532 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531001766 |
PIK3R1
|
Health Risk |
Pathogenic |
Agammaglobulinemia 7, autosomal recessive |
| RS2531001936 |
PIK3R1
|
Health Risk |
Likely pathogenic |
Vascular malformation, Vascular malformation |
| RS2531002141 |
LIFR
|
Health Risk |
Likely pathogenic |
— |